Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Squamous cell carcinoma of head and neck
ADR ID BADD_A10965
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.024      Squamous cell carcinoma of head and neck
Description The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. [MeSH]
MedDRA Code 10060121
MeSH ID D000077195
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Squamous cell carcinoma of head and neck | Squamous cell carcinoma of head and neck metastatic | Squamous Cell Carcinoma of Head and Neck | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck | Head and Neck Squamous Cell Carcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00723Doxorubicin0.000280%
BADD_D01253Lenalidomide0.000362%
The 1th Page    1    Total 1 Pages